Lysoway Therapeutics has developed technological methods to screen and develop potent modulators of lysosomal ion channels.
Lysoway Therapeutics has raised $3.4M in total funding. The most recent round was Grant. The last funding was announced in June 2026.
Lysoway Therapeutics's investors include Michael J. Fox Foundation, The Silverstein Foundation.
Lysoway Therapeutics is headquartered in Cambridge, United States.
Lysoway Therapeutics has developed technological methods to screen and develop potent modulators of lysosomal ion channels.
Lysoway Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lysoway Therapeutics — Funding & Investors." VCBacked, June 1, 2026, https://www.vcbacked.co/company/lysoway-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Lysoway Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lysoway-therapeutics
{{cite web |title=Lysoway Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lysoway-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated